2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic
Jeffrey A Towbin1, William J McKenna2, Dominic J Abrams3
1Le Bonheur Children's Hospital, Memphis, Tennessee; University of Tennessee Health Science Center, Memphis, Tennessee.
Insights
Arrhythmogenic cardiomyopathy (ACM) is a complex heart muscle disorder with diverse causes, including genetic and inflammatory conditions. This consensus provides clinical guidance on evaluating and managing ACM, focusing on exercise recommendations for arrhythmogenic right ventricular cardiomyopathy.
Area of Science:
- Cardiology
- Genetics
- Pathology
Background:
- Arrhythmogenic cardiomyopathy (ACM) encompasses a range of myocardial disorders not caused by ischemia, hypertension, or valvular disease.
- It includes conditions like arrhythmogenic right/left ventricular cardiomyopathy, cardiac amyloidosis, sarcoidosis, Chagas disease, and left ventricular noncompaction.
- ACM shares overlapping phenotypes with other cardiomyopathies, notably dilated cardiomyopathy presenting with arrhythmias.
Purpose of the Study:
- To provide clinicians with expert guidance on the evaluation and management of arrhythmogenic cardiomyopathy (ACM).
- To offer clinically relevant information on the genetics and disease mechanisms underlying ACM.
- To develop evidence-based recommendations for exercise in arrhythmogenic right ventricular cardiomyopathy using PICO questions.
Main Methods:
- Utilized PICO (Population, Intervention, Comparison, Outcome) questions to assess contemporary evidence.
- Conducted a systematic literature search with evidence tables.
- Developed recommendations based on expert consensus, literature review, and clinical experience, using the ACC/AHA Class of Recommendation and Level of Evidence system.
Main Results:
- Recommendations for ACM evaluation and management were developed.
- Specific guidance on exercise in arrhythmogenic right ventricular cardiomyopathy was formulated.
- The consensus statement integrates genetic insights and disease mechanisms.
Conclusions:
- ACM is a heterogeneous group of disorders requiring comprehensive evaluation and management strategies.
- Understanding the genetic basis of ACM is crucial for elucidating disease triggers and pathways.
- This expert consensus provides a framework for evidence-based clinical practice in ACM.
Abstract:
Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders. This designation includes, but is not limited to, arrhythmogenic right/left ventricular cardiomyopathy, cardiac amyloidosis, sarcoidosis, Chagas disease, and left ventricular noncompaction. The ACM phenotype overlaps with other cardiomyopathies, particularly dilated cardiomyopathy with arrhythmia presentation that may be associated with ventricular dilatation and/or impaired systolic function. This expert consensus statement provides the clinician with guidance on evaluation and management of ACM and includes clinically relevant information on genetics and disease mechanisms. PICO questions were utilized to evaluate contemporary evidence and provide clinical guidance related to exercise in arrhythmogenic right ventricular cardiomyopathy. Recommendations were developed and approved by an expert writing group, after a systematic literature search with evidence tables, and discussion of their own clinical experience, to present the current knowledge in the field. Each recommendation is presented using the Class of Recommendation and Level of Evidence system formulated by the American College of Cardiology and the American Heart Association and is accompanied by references and explanatory text to provide essential context. The ongoing recognition of the genetic basis of ACM provides the opportunity to examine the diverse triggers and potential common pathway for the development of disease and arrhythmia.
More Related Videos
Related Concept Videos
Cardiomyopathy VI: Nursing Management
SI Units: 2019 Redefinition
A standard set of units has been defined...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy


